Safety, Potential Efficacy, and Pharmacokinetics of PZ-601 in the Treatment of Complicated Skin and Skin Structure Infection
Public ClinicalTrials.gov record NCT00671580. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase II Randomized, Observer-Blind, Multi-Center Study to Evaluate the Safety, Potential Efficacy, and Pharmacokinetics of Two Dosing Regimens of Intravenous PZ-601 and Standard of Care in the Treatment of Complicated Skin and Skin Structure Infections
Study identification
- NCT ID
- NCT00671580
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Protez Pharmaceuticals, Inc.
- Industry
- Enrollment
- 99 participants
Conditions and interventions
Conditions
Interventions
- PZ-601 Drug
- Standard of Care Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 30, 2008
- Primary completion
- Jan 31, 2009
- Completion
- Jan 31, 2009
- Last update posted
- Jun 2, 2009
2008 – 2009
United States locations
- U.S. sites
- 15
- U.S. states
- 9
- U.S. cities
- 15
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| eStudySite - Sharp Chula Vista | Chula Vista | California | 91911 | — |
| Novellus Research Site | Fountain Valley | California | 92708 | — |
| Novellus Research Site | Long Beach | California | 90806 | — |
| eStudySite - Tri-City Medical Center | Oceanside | California | 92056 | — |
| eStudySite - Good Samaritan Hospital | San Jose | California | 95124 | — |
| Infectious Disease of Indiana, PSC | Indianapolis | Indiana | 46280 | — |
| Gulf Coast Research, LLC | Baton Rouge | Louisiana | 70808 | — |
| Henry Ford Hospital | Detroit | Michigan | 48202 | — |
| University of Missouri Health Care | Columbia | Missouri | 65212 | — |
| Truman Medical Center - Hospital Hill | Kansas City | Missouri | 64108 | — |
| Mercury Street Medical Group | Butte | Montana | 59701 | — |
| Holy Name Hospital Institute for Clinical Research | Teaneck | New Jersey | 07666 | — |
| Summa Health System | Akron | Ohio | 44304 | — |
| Remington-Davis, Inc. | Columbus | Ohio | 43215 | — |
| NewBridge Medical Research | Warren | Pennsylvania | 16365 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00671580, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 2, 2009 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00671580 live on ClinicalTrials.gov.